Mitogen-activated Protein Kinase Kinase 1 (MEK1) Stabilizes MyoD through Direct Phosphorylation at Tyrosine 156 During Myogenic Differentiation

Abstract

Previously, we reported that mitogen-activated protein kinase kinase 1 (MEK1) activated in the mid-stage of skeletal muscle differentiation promotes myogenic differentiation. To elucidate the molecular mechanism, we investigated an activity of MEK1 for MyoD. Activated MEK1 associates with MyoD in the nucleus of differentiating myoblasts. In vitro kinase assay using active MEK1, a 32 P-labeled protein band corresponding to GSTMyoD was observed but not to mutant GST-MyoD-Y156F. Tyrosine phosphorylation of endogenous MyoD was detected with a specific anti-pMyoD-Y156 antibody; however, this response was blocked by PD184352, a MEK-specific inhibitor. These results indicate that activated MEK1 phosphorylates the MyoD-Y156 residue directly. Interestingly, the protein level of mutant MyoD-Y156F decreased compared with that of wild type but was recovered in the presence of lactacystin, a proteasome inhibitor. The protein level of MyoD-Y156E, which mimics phosphorylation at Tyr-156, was above that of wild type, indicating that the phosphorylation protects MyoD from the ubiquitin proteasome-mediated degradation. In addition, the low protein level of MyoD-Y156F was recovered over that of wild type by an additional mutation at Leu-164, a critical binding residue of MAFbx/AT-1, a Skp, Cullin, F-box (SCF) E3-ubiquitin ligase. The amount of MyoD co-precipitated with MAFbx/AT-1 also was reduced in the presence of active MEK1. Thus, these results suggested that the phosphorylation probably interrupts the binding of MAFbx/AT-1 to MyoD and thereby increases its stability. Collectively, our results suggest that MEK1 activated in differentiating myoblasts stimulates muscle differentiation by phosphorylating MyoD-Y156, which results in MyoD stabilization.

Ras-activated Dsor1 promotes Wnt signaling in Drosophila development

“…Its central dogma has revolved around its simple and exclusively linear signaling series for the activation of Rl/ERK. A small number of previous studies have questioned this model, demonstrating that MEK is capable of phosphorylating other targets (Jo et al, 2011;Tang et al, 2015), even GSK3 (Takahashi-Yanaga et al, 2004). Our results are consistent with this alternative 'MEK multiple substrate model'.…”

Direct Reprogramming of Fibroblasts to Myocytes via Bacterial Injection of MyoD Protein

“…Like many transcription factors, the stability of MyoD is regulated by posttranslational modifications, such as ubiquitination, phosphorylation, acetylation, and methylation (Di Padova et al, 2007;Jo et al, 2011;Ling et al, 2012;Sadeh et al, 2008). In the case of MyoD, manipulation of these modified amino acids could not only decrease proteasomal degradation, but also desensitize ExoS54-MyoD to downregulation by cyclindependent kinases.…”

The combination of ursolic acid and leucine potentiates the differentiation of C2C12 murine myoblasts through the mTOR signaling pathway

“…While MyoD and Myf5 determine the myogenic lineage of muscle progenitor cells (3,34), myogenin and MRF4 drive the terminal differentiation and fusion of myoblasts into myotubes, the developing myofibers (35,36). MyoD is regulated by several biochemical modifications and interactions, such as ubiquitination (37), acetylation (38), phosphorylation (39) and is negatively regulated by methylation (40). In addition, it can interact with cell cycle regulators, such as retinoblastoma protein (pRB) (41) and cdk4 (42) to induce cell cycle withdrawal directly during myogenic differentiation.…”